International Immunology Advance Access originally published online on October 11, 2004
International Immunology 2004 16(12):1701-1709; doi:10.1093/intimm/dxh171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 The Japanese Society for Immunology
Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Japan
Correspondence to: T. Nakahara; E-mail: nakahara{at}dermatol.med.kyushu-u.ac.jp
Dendritic cells (DCs) are potent antigen-presenting cells that play a pivotal role in the initiation of T cell-dependent immune responses. Immature DCs obtained from peripheral blood CD14+ monocytes by culture with granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) differentiate into mature DCs upon stimulation with lipopolysaccharide (LPS). At least three families of mitogen-activated protein kinases (MAPKs), that is, extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK) and p38 MAPK, are involved in the DC maturation process. We report investigations of the role of JNK in the maturation of human monocyte-derived DCs. SP600125, a specific inhibitor of JNK, inhibited the LPS-induced up-regulation of CD80, CD83, CD86 and CD54, but augmented the up-regulation of HLA-DR. SP600125 slightly inhibited the down-regulation of FITC–dextran uptake during DC maturation. However, SP600125 did not affect the LPS induced up-regulation of allostimulatory capacity of DCs. SP600125 inhibited the release of IL-12 p70 and TNF-
from mature DCs. Although autologous T cells primed by the ovalbumin (OVA)-pulsed mature DCs produced IFN-
, but not IL-4, OVA-pulsed SP600125-treated mature DCs could initiate IL-4 production from autologous T cells. In contrast, a p38 MAPK inhibitor, SB203580, profoundly inhibited the phenotypic and functional maturation of DCs, while an ERK inhibitor, PD98059, had little or no effect. Taken together, the JNK signaling pathway appears to have a role that is distinct from the p38 MAPK and ERK cascades in the maturation process of DCs, and may be involved in the augmentation of Th2-prone T cell responses when it is suppressed.
Keywords: cytokines, mitogen-activated protein kinases, signal transduction, Th1/2 cells
Transmitting editor: S. Koyasu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Mittal, S. Bulgheresi, C. Emami, and N. V. Prasadarao Enterobacter sakazakii Targets DC-SIGN to Induce Immunosuppressive Responses in Dendritic Cells by Modulating MAPKs J. Immunol., November 15, 2009; 183(10): 6588 - 6599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Utsugi, K. Dobashi, A. Ono, T. Ishizuka, S.-i. Matsuzaki, T. Hisada, Y. Shimizu, T. Kawata, H. Aoki, Y. Kamide, et al. PI3K p110{beta} Positively Regulates Lipopolysaccharide-Induced IL-12 Production in Human Macrophages and Dendritic Cells and JNK1 Plays a Novel Role J. Immunol., May 1, 2009; 182(9): 5225 - 5231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Makela, M. Strengell, T. E. Pietila, P. Osterlund, and I. Julkunen Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells J. Leukoc. Biol., April 1, 2009; 85(4): 664 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Larange, D. Antonios, M. Pallardy, and S. Kerdine-Romer TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation J. Leukoc. Biol., April 1, 2009; 85(4): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Lee, M. Long, A. J. Adler, R. S. Mittler, and A. T. Vella The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death J. Leukoc. Biol., January 1, 2009; 85(1): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tian, S. Grimaldo, M. Fugita, J. Cutts, N. L. Vujanovic, and L.-Y. Li The Endothelial Cell-Produced Antiangiogenic Cytokine Vascular Endothelial Growth Inhibitor Induces Dendritic Cell Maturation J. Immunol., September 15, 2007; 179(6): 3742 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Uenotsuchi, S. Takeuchi, T. Matsuda, K. Urabe, T. Koga, H. Uchi, T. Nakahara, S. Fukagawa, M. Kawasaki, H. Kajiwara, et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence Int. Immunol., December 1, 2006; 18(12): 1637 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Macagno, M. Molteni, A. Rinaldi, F. Bertoni, A. Lanzavecchia, C. Rossetti, and F. Sallusto A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression J. Exp. Med., June 12, 2006; 203(6): 1481 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Palova-Jelinkova, D. Rozkova, B. Pecharova, J. Bartova, A. Sediva, H. Tlaskalova-Hogenova, R. Spisek, and L. Tuckova Gliadin Fragments Induce Phenotypic and Functional Maturation of Human Dendritic Cells J. Immunol., November 15, 2005; 175(10): 7038 - 7045. [Abstract] [Full Text] [PDF]
|
|